News

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that affects motor neurons, leading to ...
The ALS market is witnessing robust growth driven by increased disease awareness, advancements in genetic research, and an expanding pipeline of ther ...
The motor neuron disease treatment market is witnessing substantial growth, primarily fueled by the rising incidence of conditions like Amyotrophic L ...
BrainStorm Cell Therapeutics Inc. shares crashed 42.74% to $0.67 in after-hours trading on Friday after the company announced ...
CB03-154 is a newer ALS therapy that's designed to open nerve cells' KCNQ2 and KCNQ3 potassium channels without affecting ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a new gene therapy for Amyotrophic Lateral ...
Salym Liufau was at a family birthday party in 2022 when she squatted to pick up her kids, a motion she’d done a million times as a busy mom of four. But, when she couldn't get up, she realized ...
KLTO‑202 is an experimental gene therapy that would deliver the instructions for a protein that may reduce inflammation and ...
Bring Me the News reports how the death of Matt Keil — who served as the bassist for Winnipeg, Canada-based outfit Comeback ...
At more than 70 locations from around the state of Nebraska, the 2025 Cornhusker State Games kicked-off on July 10. For the ...
US FDA grants orphan drug designation to Klotho Neurosciences’ KLTO-202 to treat amyotrophic lateral sclerosis: New York Saturday, July 12, 2025, 15:00 Hrs [IST] Klotho Neurosci ...